The Impact of BPH and Management of Prostate Cancer Obesity in Urology

Dr. Steven A. Kaplan is the Director of the Men’s Wellness Program at Mount Sinai Health System and a Professor of Urology at the Icahn School of Medicine at Mount Sinai. He is an internationally renowned leader in the study of benign diseases of the prostate, the association of metabolic factors with voiding dysfunction, and female urology.

Dr. Kaplan graduated from Mount Sinai School of Medicine in 1982. Dr. Kaplan’s postgraduate training included an internship and residency in the Department of Surgery at Mount Sinai Hospital, as well as a residency in urology at the Squier Urologic Clinic at Columbia University.

Dr. Kaplan is a Diplomat of the American Board of Urology and a Fellow of the American College of Surgeons. He is a writer on over 1000 publications, and he is also the co-author of five books and is on the editorial boards of numerous journals, including Urology, the Journal of Urology, and the Urology Times. His landmark study, published in JAMA in 2006, changed the way medications are used in the treatment of men with symptoms related to both benign prostate enlargement and bladder dysfunction.

Dr. Kaplan joined Mount Sinai from Weill Cornell Medical College, where he held the tenured position of E. Darracott Vaughan, Jr., Professor of Urology, and also served as Director of the Iris Cantor Men’s Health Center. While at Weill Cornell Medical College, he was actively engaged in teaching and supervising residents and fellows, and was the Director of the Fellowship Program in Male and Female Voiding Dysfunction. He also held the tenured position of Given Foundation Professor of Urology at Columbia University and was the Vice Chairman and Program Director.